Docel 20 Combipack Injection 0.5 ml

Docel 20 Combipack Injection 0.5 ml belongs to the class of 'anti-neoplastic/anti-cancer drugs', primarily used as a chemotherapy drug to treat cancers. It is effectively used in breast, lung, prostate, stomach, head/neck cancers. Cancer is a genetic change in which our cells divide uncontrollably and spread into surrounding tissues.

Docel 20 Combipack Injection 0.5 ml contains Docetaxel, which belongs to the anticancer drugs. It works by slowing down cell growth. It is a cytotoxic agent, i.e., it prevents the cancer cells from rapidly dividing and spreading.

Docel 20 Combipack Injection 0.5 ml will be administered by a healthcare professional. Your doctor will decide the dosage depending on your medical condition. The common side effects of Docel 20 Combipack Injection 0.5 ml include pain/swelling at the injection site, headache, fatigue, dizziness, drowsiness, constipation, loss of appetite, indigestion, tearing of the eyes, nausea, vomiting, diarrhoea, insomnia (sleeplessness), fever (please inform your doctor if you have fever), muscle aches, and breathlessness. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.

Do not use or stop this medicine if the doctor did not advise you. Before starting Docel 20 Combipack Injection 0.5 ml, let your doctor know if you have any allergic reactions, medical history of liver or kidney diseases, heart diseases, blood pressure problems, fits, lung disorders, weak immune system, anemia, low white blood cell count, vision problems, and are receiving chemotherapy. Docel 20 Combipack Injection 0.5 ml is not indicated for use in pregnant and breastfeeding women. Docel 20 Combipack Injection 0.5 ml may make you feel dizzy and drowsy, hence do not drive or operate machinery. It is not recommended to consume alcohol along with Docel 20 Combipack Injection 0.5 ml. Docel 20 Combipack Injection 0.5 ml is not recommended for children below two years of age.

Docel 20 Combipack Injection 0.5 ml used in the treatment of Cancer. The detailed uses of Docel 20 Combipack Injection 0.5 ml are as follows:

• Breast Cancer: Docel 20 Combipack Injection 0.5 ml helps to treat breast cancer by slowing or stopping tumor growth.
• Lung Cancer: Docel 20 Combipack Injection 0.5 ml is used to treat non-small cell lung cancer, a common type of lung cancer.
• Prostate Cancer: Docel 20 Combipack Injection 0.5 ml helps treat advanced prostate cancer, reducing tumor size and slowing growth.
• Gastric Cancer: Docel 20 Combipack Injection 0.5 ml is used to treat stomach cancer, inhibiting cancer cell proliferation.
• Head and Neck Cancer: Docel 20 Combipack Injection 0.5 ml helps treat head and neck cancer, slowing tumor growth and spread.

• Follow your doctor's instructions on the dosage and timing of this medication.
• Docel 20 Combipack Injection 0.5 ml will be administered by a nurse or doctor.
• Do not self-administer.

Docel 20 Combipack Injection 0.5 ml contains Docetaxel that belongs to the family of anticancer drugs. It works by slowing down cell growth. It is a cytotoxic agent and prevents cancer cells from rapidly dividing and spreading. Docetaxel may be used alone or in combination with other chemotherapy drugs to treat breast cancer that has spread to the tissues and lymph nodes (locally advanced breast cancer) and other parts (secondary breast cancer). It is also used in prostate cancer that does not respond to hormone treatment. It is further being investigated to treat small cell lung, ovarian, bladder, and pancreatic cancers.

Inform your doctor if you have any allergic reactions to Docel 20 Combipack Injection 0.5 ml or other medications. Before starting Docel 20 Combipack Injection 0.5 ml, let your doctor know if you have any medical history of allergic reactions, non-small cell lung cancer, liver or kidney diseases, heart diseases (congestive heart failure), blood pressure problems, fits, lung disorders (pulmonary effusions), weak immune system, anemia, low white blood cell count/thrombocytopenia, vision problems, and are already receiving chemotherapy. Docel 20 Combipack Injection 0.5 ml can affect the unborn baby when used in pregnancy. It may also have harmful effects on the breastfed infant when used by a lactating mother. Hence, Docel 20 Combipack Injection 0.5 ml is not indicated in pregnancy and breastfeeding women. If you are using Docel 20 Combipack Injection 0.5 ml, use reliable contraception forms to prevent pregnancy during the course. Docel 20 Combipack Injection 0.5 ml can make you feel dizzy and drowsy, thus affecting your mental ability to drive. Do not drive or operate machinery if you are not mentally alert and focused. Avoid alcohol consumption while being treated with Docel 20 Combipack Injection 0.5 ml. Docel 20 Combipack Injection 0.5 ml is not recommended for patients younger than 18 years of age.